Enasidenib-Induced Eosinophilic Differentiation in a Patient With Acute Myeloid Leukaemia With IDH2 and U2AF1 Mutations

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15609
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Enasidenib, an Inhibitor of Mutant IDH2 Proteins, Induces Durable Remissions in Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2019English

Identification of FLT3 and NPM1 Mutations in Patients With Acute Myeloid Leukaemia

Asian Pacific Journal of Cancer Prevention
2019English

Chronic Eosinophilic Leukemia Transformation Into Acute Myeloid Leukemia With Monocytic Differentiation

Case Reports in Internal Medicine
2014English

8 Treatment of the Elderly Patient With Acute Myeloid Leukaemia

Baillière's Clinical Haematology
1996English

Adult Acute Myeloid Leukemia With Trisomy 11 as the Sole Abnormality Is Characterized by the Presence of Five Distinct Gene Mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2016English

Acute Eosinophilic Monoarthritis in a Patient With Toxocariasis

The Korean Journal of Medicine
2018English

Highly Atypical Myeloblasts in Acute Myeloid Leukaemia With Myelodysplasia-Related Changes in a Patient With Short Telomere Syndrome

British Journal of Haematology
Hematology
2018English

IDH1 and IDH2 Mutations in Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia Are Associated With a Normal Karyotype and With Der(1;7)(q10;p10)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

Pathological Findings on Eosinophilic Myeloid Leukaemia in a Sow

Journal of the Japan Veterinary Medical Association
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy